Systems and methods for determining lesion depth using fluorescence imaging

Patent metadata

Field	Value
Publication number	US-12343114-B2
Application number	US-202117388312-A
Country	US
Kind code	B2
Filing date	Jul 29, 2021
Priority date	Nov 14, 2013
Publication date	Jul 1, 2025
Grant date	Jul 1, 2025

Abstract

Systems, catheter and methods for treating Atrial Fibrillation (AF) are provided, which are configure to illuminate a heart tissue having a lesion site; obtain a mitochondrial nicotinamide adenine dinucleotide hydrogen (NADH) fluorescence intensity from the illuminated heart tissue along a first line across the lesion site; create a 2-dimensional (2D) map of the depth of the lesion site along the first line based on the NADH fluorescence intensity; and determine a depth of the lesion site at a selected point along the first line from the 2D map, wherein a lower NADH fluorescence intensity corresponds to a greater depth in the lesion site and a higher NADH fluorescence intensity corresponds to an unablated tissue. The process may be repeated to create a 3 dimensional map of the depth of the lesion.

First claim

What is claimed is:

1. A system for imaging tissue comprising:
an illumination device comprising a light source configured to illuminate a tissue having a lesion site comprising two or more lesions and at least one interlesion gap to excite mitochondrial nicotinamide adenine dinucleotide hydrogen (NADH) in the tissue;
an imaging device comprising a sensor configured to detect NADH fluorescence from the illuminated tissue;
a controller in communication with the imaging device, the controller being programmed to receive data, from the imaging device, indicative of intensity of a mitochondrial nicotinamide adenine dinucleotide hydrogen (NADH) fluorescence from the illuminated tissue having the lesion site; create a digital image of the lesion site from the detected intensity of NADH fluorescence of the lesion site, the digital image comprising information about a depth of the two or more lesions; analyze the digital image of the detected intensity of NADH fluorescence of the lesion site to extract the information about the depth and shape of the two or more lesions and the at least one interlesion gap of the lesion site by creating a plurality of 2-dimensional (2D) maps of the depth and shape of the two or more lesions and the at least one interlesion gap of the lesion site along a plurality of lines across the digital image of the lesion site based on the detected NADH fluorescence intensity; construct a 3-dimensional (3D) image of the two or more lesions and of the at least one interlesion gap of the lesion site from the plurality of 2D maps such that the 3D image is representative of the depth and shape of the two or more lesions and the at least one interlesion gap of the lesion site; and cause the 3D image of the depth and shape of the two or more lesions and the at least one interlesion gap to be displayed to a user.

2. The system of claim 1 , wherein the tissue is a heart tissue.

3. The system of claim 1 , wherein the tissue is selected from the group consisting of epicardial tissue, endocardial tissue, atrial tissue, and ventricular tissue.

4. The system of claim 1 , wherein the illumination device is a UV laser.

5. The system of claim 1 , wherein the imaging device comprises a camera and a fiberscope extending from the camera to the tissue being illuminated.

6. The system of claim 1 , wherein the imaging device further includes a bandpass filter of between 435 nm and 485 nm disposed between a camera and a fiberscope.

7. The system of claim 1 , further comprising a catheter having a distal end configured to be positioned adjacent to the lesion site having one or more lesions in a tissue, wherein the catheter includes one or more optical fibers such that a distal end of the one or more optical fibers extends to the distal end of the catheter.

8. A system for imaging tissue comprising:
an imaging device comprising a sensor configured to detect NADH fluorescence from tissue illuminated with light;
a controller in communication with the sensor of the imaging device, the controller being programmed to:
receive data, from the imaging device, indicative of an intensity of NADH fluorescence from the illuminated tissue, the illuminated tissue including a lesion site comprising two or more lesions and at least one interlesion gap,
create a digital image of the lesion site from the NADH fluorescence intensity of the lesion site, wherein the digital image comprises information about a depth of the two or more lesions and the at least one interlesion gap of the lesion site;
analyze the digital image of detected intensity of NADH fluorescence of the lesion site to extract the information about the depth of the two or more lesions and the at least one interlesion gap of the lesion site by creating a plurality of 2-dimensional (2D) maps of the depth and shape of the two or more lesions and the at least one interlesion gap of the lesion site along a plurality of parallel lines across the digital image of the lesion site based on the detected NADH fluorescence intensity, the plurality of parallel lines being perpendicular to a line across a width of the lesion site;
construct a 3-dimensional (3D) image of the depth and shape of the two or more lesions and the at least one interlesion gap of the lesion site in the digital image from the plurality of 2D maps along the plurality of lines; and
cause the 3D image of the depth and shape of the two or more lesions and the at least one interlesion gap to be displayed to a user.

9. The system of claim 8 , wherein the one or more lesions comprises two or more lesions and at least one interlesion gap, and the 3D image illustrates the depth of the two or more lesions and of the at least one interlesion gap.

10. A method for operating a system for determining a depth of a lesion site, the method comprising:
by a controller, receiving data, from an imaging device, indicative of intensity of a mitochondrial nicotinamide adenine dinucleotide hydrogen (NADH) fluorescence from an illuminated tissue having a lesion site comprising two or more lesions and at least one interlesion gap;
by the controller, creating a digital image of the lesion site from detected intensity of NADH fluorescence of the lesion site, the digital image comprising information about a depth and shape of the two or more lesions and at least one interlesion gap;
by the controller, analyzing the digital image of the detected intensity of NADH fluorescence of the lesion site to extract the information about the depth and shape of the lesion site by creating a plurality of 2-dimensional (2D) maps of the depth and shape of the two or more lesions and at least one interlesion gap of the lesion site along a plurality of parallel lines across the digital image of the detected NADH fluorescence intensity of the lesion site;
by the controller, constructing a 3-dimensional (3D) image of the depth and shape of the two or more lesions and at least one interlesion gap of the lesion site in the digital image from the plurality of 2D maps along the plurality of parallel lines; and
by the controller, causing the 3D image of the depth and shape of the two or more lesions and the at least one interlesion gap of the lesion site to be displayed.

11. The method of claim 10 , wherein the tissue is a heart tissue.

12. The method of claim 10 , wherein the tissue is selected form the group consisting of epicardial tissue, endocardial tissue, atrial tissue, and ventricular tissue.

13. The method of claim 10 , wherein the step of receiving data comprises obtaining the NADH fluorescence from the tissue having the lesion site formed by an ablation device.

14. The method of claim 10 , further comprising;
distinguishing the lesion site and a healthy tissue in the digital image based on an amount of the NADH fluorescence from the lesion site and the healthy tissue; and
normalizing the digital image based on the NADH fluorescence intensity of pixels representative of the healthy tissue.

15. The method of claim 14 , wherein the healthy tissue has a lighter appearance and the lesion site has a darker appearance.

16. The method of claim 10 , wherein the step of receiving data comprises filtering the NADH fluorescence through a bandpass filter of between 435 nm and 485 nm.

17. The method of claim 10 , wherein the step of creating comprises plotting the NADH fluorescence intensity along the line across the lesion site to create the 2D map of depth of the lesion site.

18. The method of claim 10 , further comprising an illuminating device for generating a UV light.

19. The metho

Assignees

• Univ George Washington
• 460Medical Inc

Inventors

• Mercader Marco A
• Sarvazyan Narine
• Ransbury Terrance J
• Armstrong Kenneth C
• Amirana Omar

Classifications

• A61B2576/023

  for the heart · CPC title

• A61B2018/00351

  Heart · CPC title

• A61B5/02028

  Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction · CPC title

• A61B5/0084

  for introduction into the body, e.g. by catheters (A61B5/1459 takes precedence) · CPC title

• A61B5/0044

  for the heart · CPC title